Company Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Dr. Lal PathLabs Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories

Market Closed - NSE India S.E. Other stock markets 07:43:55 2024-06-28 EDT			5-day change	1st Jan Change
2,781 ^INR	+1.19%		+4.01%	+7.88%

05-14	Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505	MT
05-10	Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Number of employees: 4,099

INR in Million	2023	Weight	2024	Weight	Delta
Laboratories for Carrying Out Pathological Investigations 100.0 %	20,166	100.0 %	22,265	100.0 %	+10.41%
Other 0.0 %	2	0.0 %	1	0.0 %	-41.84%

INR in Million	2023	Weight	2024	Weight	Delta
India 98.8 %	19,949	98.9 %	22,007	98.8 %	+10.32%
International 1.2 %	220	1.1 %	259	1.2 %	+17.58%

Managers	Title	Age	Since
Shankha Banerjee CEO	Chief Executive Officer	-	14-06-30
Ved Prakash Goel DFI	Director of Finance/CFO	-	05-12-31
Arvind Lal CHM	Chairman	74	95-02-13
Munender Soperna CTO	Chief Tech/Sci/R&D Officer	-	07-08-31
Vinay Gujral CMP	Compliance Officer	-	19-11-30
Vandana Lal CTO	Chief Tech/Sci/R&D Officer	68	95-02-13
Om Prakash Manchanda BRD	Director/Board Member	58	05-01-31
Manoj Garg HRO	Human Resources Officer	-	-

Members of the board	Title	Age	Since
Gurinder Singh Kalra BRD	Director/Board Member	58	23-07-26
Arun Kumar Sardari Duggal BRD	Director/Board Member	77	15-08-20
Arvind Lal CHM	Chairman	74	95-02-13
Vandana Lal CTO	Chief Tech/Sci/R&D Officer	68	95-02-13
Om Prakash Manchanda BRD	Director/Board Member	58	05-01-31
Rajit Mehta BRD	Director/Board Member	-	23-07-26
Rahul Sharma BRD	Director/Board Member	63	05-07-21
Archana Lal Erdmann BRD	Director/Board Member	43	19-05-16
Somya Satsangi BRD	Director/Board Member	54	19-02-07
Rohit Bhasin BRD	Director/Board Member	64	22-11-07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	83,480,302	36,249,094 ( 43.42 %)	264,725 ( 0.3171 %)	43.42 %

Name	Equities	%	Valuation
Arvind Lal 31.64 %	26,415,443	31.64 %	838 M ₹
Vandana Lal 19.26 %	16,082,327	19.26 %	510 M ₹
UTI Asset Management Co. Ltd. (Investment Management) 3.883 %	3,241,802	3.883 %	103 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt) 2.402 %	2,005,452	2.402 %	64 M ₹
Archana Lal Erdmann 2.029 %	1,693,751	2.029 %	54 M ₹
Anjaneya Lal 2.024 %	1,689,614	2.024 %	54 M ₹
Life Insurance Corporation of India (Investment Portfolio) 1.475 %	1,231,246	1.475 %	39 M ₹
First Sentier Investors (Hong Kong) Ltd. 1.141 %	952,626	1.141 %	30 M ₹
Om Prakash Manchanda 1.081 %	902,164	1.081 %	29 M ₹
Al Mehwar Commercial Investments LLC 1.057 %	882,188	1.057 %	28 M ₹

Dr. Lal PathLabs Ltd.

12th Floor, Tower B, SAS Tower Medicity, Sector-38

122001, Gurgaon

+91 12 4301 6500

http://www.lalpathlabs.com

address Dr. Lal PathLabs Limited(LALPATHLAB)

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,781 INR

Average target price

2,543 INR

Spread / Average Target

-8.56%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
DR. LAL PATHLABS LIMITED	+7.88%	2.78B
SONIC HEALTHCARE LIMITED	-18.02%	8.43B
RADNET, INC.	+69.46%	4.35B
SYNLAB AG	-1.93%	2.64B
NEOGENOMICS, INC.	-14.28%	1.77B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-56.54%	1.74B
FLEURY S.A.	-16.69%	1.48B
METROPOLIS HEALTHCARE LIMITED	+17.87%	1.22B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-49.60%	1.02B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+10.83%	922M

Medical & Diagnostic Laboratories